Works by Tuominen, Rainer

Results: 16
    1
    2

    Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors.

    Published in:
    Molecular Systems Biology, 2018, v. 14, n. 3, p. 1, doi. 10.15252/msb.20177858
    By:
    • Azimi, Alireza;
    • Caramuta, Stefano;
    • Seashore‐Ludlow, Brinton;
    • Boström, Johan;
    • Robinson, Jonathan L;
    • Edfors, Fredrik;
    • Tuominen, Rainer;
    • Kemper, Kristel;
    • Krijgsman, Oscar;
    • Peeper, Daniel S;
    • Nielsen, Jens;
    • Hansson, Johan;
    • Egyhazi Brage, Suzanne;
    • Altun, Mikael;
    • Uhlen, Mathias;
    • Maddalo, Gianluca
    Publication type:
    Article
    3
    4

    PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89389-9
    By:
    • Vidarsdottir, Linda;
    • Azimi, Alireza;
    • Das, Ishani;
    • Sigvaldadottir, Ingibjorg;
    • Suryo Rahmanto, Aldwin;
    • Petri, Andreas;
    • Kauppinen, Sakari;
    • Ingvar, Christian;
    • Jönsson, Göran;
    • Olsson, Håkan;
    • Frostvik Stolt, Marianne;
    • Tuominen, Rainer;
    • Sangfelt, Olle;
    • Pokrovskaja Tamm, Katja;
    • Hansson, Johan;
    • Grandér, Dan;
    • Egyházi Brage, Suzanne;
    • Johnsson, Per
    Publication type:
    Article
    5
    6
    7
    8

    Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations.

    Published in:
    Human Genetics, 2016, v. 135, n. 11, p. 1241, doi. 10.1007/s00439-016-1715-1
    By:
    • Yang, Xiaohong;
    • Rotunno, Melissa;
    • Xiao, Yanzi;
    • Ingvar, Christian;
    • Helgadottir, Hildur;
    • Pastorino, Lorenza;
    • Doorn, Remco;
    • Bennett, Hunter;
    • Graham, Cole;
    • Sampson, Joshua;
    • Malasky, Michael;
    • Vogt, Aurelie;
    • Zhu, Bin;
    • Bianchi-Scarra, Giovanna;
    • Bruno, William;
    • Queirolo, Paola;
    • Fornarini, Giuseppe;
    • Hansson, Johan;
    • Tuominen, Rainer;
    • Burdett, Laurie
    Publication type:
    Article
    9
    10
    11
    12

    Hereditary uveal melanoma: A report of a germline mutation in BAP1.

    Published in:
    Genes, Chromosomes & Cancer, 2013, v. 52, n. 4, p. 378, doi. 10.1002/gcc.22035
    By:
    • Höiom, Veronica;
    • Edsgärd, Daniel;
    • Helgadottir, Hildur;
    • Eriksson, Hanna;
    • All‐Ericsson, Charlotta;
    • Tuominen, Rainer;
    • Ivanova, Ivayla;
    • Lundeberg, Joakim;
    • Emanuelsson, Olof;
    • Hansson, Johan
    Publication type:
    Article
    13
    14
    15

    MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma.

    Published in:
    International Journal of Cancer, 2015, v. 136, n. 12, p. 2844, doi. 10.1002/ijc.29332
    By:
    • Tuominen, Rainer;
    • Jewell, Rosalyn;
    • van den Oord, Joost J.;
    • Wolter, Pascal;
    • Stierner, Ulrika;
    • Lindholm, Christer;
    • Hertzman Johansson, Carolina;
    • Lindén, Diana;
    • Johansson, Hemming;
    • Frostvik Stolt, Marianne;
    • Walker, Christy;
    • Snowden, Helen;
    • Newton‐Bishop, Julia;
    • Hansson, Johan;
    • Egyházi Brage, Suzanne
    Publication type:
    Article
    16